HR 9632

0likes☆Favorite🔕SubscribeShare

Introduced ↻ Update bill dataRe-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click. Contact your reps Urge the sponsor

IN THE HOUSE OF REPRESENTATIVES

July 9, 2026

Mr. McCaul (for himself, Mr. Bera, and Mr. Kelly of Pennsylvania) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To better coordinate Federal efforts to utilize advance technologies, such as AI, to improve diagnoses, treatments, cures, and prevention strategies for pediatric cancer, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “Accelerating Innovation (AI) for Kids with Cancer Act”.

SEC. 2. HARNESSING UNITED STATES AI INNOVATION TO TREAT AND CURE PEDIATRIC CANCER.

(a) In General.—The President, in consultation with the Secretary of Health and Human Services (in this section referred to as the “Secretary”), shall appoint an individual or entity to serve as the coordinator of Federal efforts to utilize advance technologies, such as AI, to improve diagnoses, treatments, cures, and prevention strategies for pediatric cancer. Such individual or entity shall be known as the Coordinator of AI Innovation (in this section referred to as the “Coordinator”). The Coordinator shall serve as a member of the Domestic Policy Council.

(b) Identification of CCDI Opportunities.—In carrying out subsection (a), the Coordinator shall identify opportunities to accelerate the progress of AI-driven solutions at the Childhood Cancer Data Initiative (in this section referred to as the “CCDI”), including—

(1) by improving clinical trial design and access through incorporating AI approaches;

(2) by making data platforms and tools available as part of the CCDI Data Ecosystem;

(3) by improving data infrastructure through consolidating data from multiple sources for AI-ready analysis and through utilizing AI to better select participants for clinical trials;

(4) by enhancing data analysis through integration with AI tools—

(A) to improve predictive modeling of patient response, disease progression, and treatment toxicity; and

(B) to turn multi-omics data and imaging data into novel diagnostic, prognostic, and therapeutic biomarkers; and

(5) by improving clinical trial design, access, and outcomes for patients by incorporating multimodal data and using AI approaches.

(c) Improving Data Sharing and Empowering Patients.—

(1) Integration of ai innovation into current work on interoperability.—The Secretary shall work to ensure that AI innovation is appropriately integrated into current work on interoperability to maximize the potential for electronic health records and claims data to inform private sector and academic research and clinical trial design, while ensuring that individuals (or authorized representatives) control their health information.

(2) Interoperability standards for patient data to be used with ai.—The Secretary shall work to finalize interoperability standards for patient data to be used with AI that—

(A) appropriately account for structured and unstructured data; and

(B) enable safe and privacy-compliant exchanges of data.

(d) Report.—Not later than 180 days after the date of the enactment of this Act, the Secretary shall submit to the appropriate committees of Congress a report on the implementation of this section.

(e) Definitions.—In this section:

(1) Artificial intelligence; ai.—The terms “artificial intelligence” and “AI” have the meaning given the term “artificial intelligence” in section 5002 of the National Artificial Intelligence Initiative of 2020 (15 U.S.C. 9401).

(2) Appropriate committees of congress.—The term “appropriate committees of Congress” means—

(A) the Committee on Energy and Commerce of the House of Representatives;

(B) the Committee on Science, Space, and Technology of the House of Representatives;

(C) the Committee on Health, Education, Labor, and Pensions of the Senate; and

(D) the Committee on Commerce, Science, and Transportation of the Senate.

(f) Authorization of Appropriations.—

(1) In general.—There are authorized to be appropriated to carry out this section such funds as may be necessary for each of fiscal years 2027 through 2031.

(2) CCDI.—In addition to amounts made available to carry out this section under paragraph (1) for a fiscal year, there is authorized to be appropriated to carry out subsection (b), $100,000,000 for each of fiscal years 2027 through 2031. <all>